FDA Investigator Thomas Cote
Thomas Cote has inspections in 7 countries as of 04 Oct 2023. Thomas Cote has collaborated with a combined 3168 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
628
Last Inspection Date:
04 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Greece,
China,
Portugal,
Taiwan,
United Kingdom of Great Britain and Northern Ireland,
Japan
Co-Investigator(s):
Aaron L Morris,
Abraham M Maekele,
Alan R Condon,
Aldo J Quintana,
Alice C Silva,
Alois P Provost,
Alysia M Salonia,
Amber G Wardwell,
Amy C Jordan,
Andrew M Barlow,
Andrew P Abban,
Anne E Carpenter,
Annemarie L Buchholz,
Anthony N Onianwa,
Anthony P Costello,
Anthony W Thomas,
Ashley M Whitehurst,
Atricia L Irons,
Ayorinde O Babalola,
Barbara L Williams,
Bernardica T Sculac Stern,
Bill Tacket, Jr,
Bradford L Swanson,
Brant M Schroeder,
Brenda P King,
Brenna L Macdowell,
Carla C Tuite,
Carla E Lavallee,
Carol S Davis,
Cassandra L Abellard,
Christine L Williams,
Christopher K Vantwuyver,
Christopher M Elliott,
Clinton V Giustra,
Courtney N Long,
Danielle Lyke,
Darin S Wiegers,
Daryl A Dewoskin,
David P King,
David R Delucia,
Diantha M Bleau,
Donahue,
Donald J Ullstrom,
Dorothy W Lee,
Douglas S Joslin,
Eduardo L Rodriguez,
Elise L Mcdevitt,
Elizabeth B Griffin,
Ellen P Madigan,
Erica L Nicoll,
Erich P Garger,
Ernest A Clausnitzer,
Frank J Koch,
Frank J Mazzoni,
Frank K Fulford,
Gale E Ryan,
Garry H Stewart,
Gayle J Gehrman,
Gena M Mckahan,
Gerard D Difiore,
Griffin,
Helen J Hamaoka,
Hien Albright,
Hill,
Humberto Z Gomez,
Irons,
Isaac K Carney,
Isaac N Baah,
Ismael Garibay,
James P Finn,
Jamie S Mathews,
Jane Chen,
Jason A Rossi,
Jason D Tenney,
Jason Kwong,
Jay M Patria,
Jayaleka J Amarasinghe,
Jeffery A Hangartner,
Jeffrey S Buckser,
John A Hollings,
John Dan,
John P Shelton,
John R Carlson,
Jonathan B Lewis,
Jonathan G Matrisciano,
Joppie,
Joseph B Cascio,
Joseph Foley,
Joseph H Procopio,
Joshua L Gibbs,
Joyce A Kellett,
Karen M Willis,
Karen Mcnabb Noon,
Kathleen E Mcafoose,
Kathleen M Curry,
Keith A Schwartz,
Kent A Conforti,
Kimberly A Coward,
Kimberly J Langello,
Kimberly M White,
Kimberly N Garner,
Kyle J Spencer,
Lauren M Lawrance,
LCDR Debra Emerson,
Leo J Lagrotte,
Lisa H Nakagawa,
Liz M Otero,
Lorayne A Mcguinness,
Louis Christy,
Marcia M Laughrey,
Marie Elena C Puleo,
Mario A Hernandez,
Mark E Farrell,
Martin J Guardia,
Mary B Yebba,
Maryam Tabatabaie,
Maureen E Hannon,
Maxim,
Mcgrewp,
Melinda B Lewis,
Michael E Antaya,
Michael G Sinkevich,
Michael P Sweeney,
Michael R Dominick,
Michele C Murray Schrade,
Michelle M Noe,
Mikayla K Deardorff,
Monica C Forrest,
Nasser Yazdani,
Nealie C Newberger,
Nicholas J Scire,
Nichole B Murphy,
Nympha V Florendo,
Onieka T Carpenter,
Osama A Khatib,
Pamela L Ogonowski,
Paul M Gelfand,
Perez,
Peter M Trunk,
Peter R Caparelli,
Philip H Lafleur,
Ramcharan S Khalsa,
Raymond M Lam,
Rebecca A Coleman,
Rebecca B Welch,
Remal,
Richard F Hapke,
Richard G Fochesato,
Richard L Licari,
Richard W Skodinski,
Rita F Monfort,
Robert E Moncayo,
Robert Mo Brien,
Robert W Calais,
Rupa Pradhan,
Sara Jdent Acosta,
Sean M Tessicini,
Seemay A Lee,
Shawn M Bogdan,
Slater K Bartlett,
Sonia E Ortiz,
State Agency,
Stephanie M Roberts Pedotti,
Stephen C King,
Steven M Ferrara,
Susanne M Richardson, MSc RAC ELS,
Suwaskie S Smith,
Teddy Tom,
Thomas H Jenkins,
Thomas J Kelly,
Thomas J Murphy,
Thomas Siebertz,
Thomas W Nerney,
Timothy M Glod,
Tracy L Reed,
Troy R Petrillo,
Valerie A Potopsingh,
Victoria Taylor,
Wendy A Johnecheck,
Weston K Szymanski,
William K Dagley,
William M Rennells,
Yuyan Liang
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more